Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain

Neuron

Volumn 40, Issue 6, 2003, Pages 1133-1145

  Brionne, Thomas C ^a   Tesseur, Ina ^a   Masliah, Eliezer ^b   Wyss Coray, Tony ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL ACTIVATION; CELL DAMAGE; CELL DEGENERATION; CELL SURVIVAL; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXICITY; GLIOSIS; MACROGLIA; MOUSE; MOUSE STRAIN; NERVE CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

EID: 0347362913     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00766-9     Document Type: Article

References (67)

1. Alcantara S., Frisen J., del Rio J.A., Soriano E., Barbacid M., Silos-Santiago I. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 17:1997;3623-3633.
2. Bonyadi M., Rusholme S.A.B., Cousins F.M., Su H.C., Biron C.A., Farrall M., Akhurst R.J. Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat. Genet. 15:1997;207-211.
3. -/- mice. isoform-specific effects on neurodegeneration in vivo J. Neurosci. 19:1998;4867-4880.
4. Chagraoui H., Giraudier S., Vainchenker W., Wendling F. Adenoviral supply of active transforming growth factor-beta1 (TGF-beta1) did not prevent lethality in transforming growth factor-beta1-knockout embryos. Eur. Cytokine Netw. 12:2001;561-567.
5. Chalazonitis A., Kalberg J., Twardzik D.R., Morrison R.S., Kessler J.A. Transforming growth factor beta has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152:1992;121-132.
6. Chen Z.L., Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 91:1997;917-925.
7. Chen W.J., Frank M.E., Jin W., Wahl S.M. TGF-β released by apoptotic T cells contributes to an immunosuppresive milieu. Immunity. 14:2001;715-725.
8. Chin J., Angers A., Cleary L.J., Eskin A., Byrne J.H. Transforming growth factor β1 alters synapsin distribution and modulates synaptic depression in Aplysia. J. Neurosci. 22:2002;1-6.
9. Dennler S., Goumans M.-J., ten Dijke P. Transforming growth factor β signal transduction. J. Leukoc. Biol. 71:2002;731-740.
10. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 121:1995;1845-1854.
11. Diebold R.J., Eis M.J., Yin M., Ormsby I., Boivin G.P., Darrow B.J., Saffitz J.E., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA. 92:1995;12215-12219.
12. Dünker N., Schuster N., Krieglstein K. TGF-β modulates programmed cell death in the retina of the developing chick embryo. Development. 128:2001;1933-1942.
13. Ebendal T., Bengtsson H., Soderstrom S. Bone morphogenetic proteins and their receptors. potential functions in the brain J. Neurosci. Res. 51:1998;139-146.
14. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898.
15. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A.B., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:2000;85-90.
16. Farkas L.M., Dunker N., Roussa E., Unsicker K., Krieglstein K. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J. Neurosci. 23:2003;5178-5186.
17. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53:1993;314-322.
18. Flanders K.C., Ren R.F., Lippa C.F. Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 54:1998;71-85.
19. Freire-de-Lima C.G., Nascimento D.O., Soares M.B.P., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., DosReis G.A., Lopes M.F. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature. 403:2000;199-203.
20. 1 null mouse phenotype Proc. Natl. Acad. Sci. USA. 90:1993;9944-9948.
21. Gleeson J.G., Allen K.M., Fox J.W., Lamperti E.D., Berkovic S., Scheffer I., Cooper E.C., Dobyns W.B., Minnerath S.R., Ross M.E., Walsh C.A. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 92:1998;63-72.
22. Grainger D.J., Heathcote K., Chiano M., Sneider H., Kemp P.R., Metcalfe J.C., Carter N.D., Spector T.D. Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Genet. 8:1999;93-97.
23. Hecker K.H., Roux K.H. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques. 20:1996;478-485.
24. Huang E.J., Reichardt L.F. Neurotrophins. roles in neuronal development and function Annu. Rev. Neurosci. 24:2001;677-736.
25. Indyk J.A., Chen Z.L., Tsirka S.E., Strickland S. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience. 116:2003;359-371.
26. Johnson E.M. Jr., Deckwerth T.L. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16:1993;31-46.
27. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
28. Kim S.-J., Angel P., Lafyatis R., Hattori K., Kim K.Y., Sporn M.B., Karin M., Roberts A.B. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1990;1492-1497.
29. Krieglstein K., Reuss B., Maysinger D., Unsicker K. Transforming growth factor-β mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons. Eur. J. Neurosci. 10:1998;2746-2750.
30. Krieglstein K., Richter S., Farkas L., Schuster N., Dunker N., Oppenheim R.W., Unsicker K. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat. Neurosci. 3:2000;1085-1090.
31. Kulkarni A.B., Huh C.-H., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M., Ward J.M., Karlson S. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:1993;770-774.
32. Letterio J.J. Murine models define the role of TGF-β as a master regulator of immune cell function. Cytokine Growth Factor Rev. 11:2000;81-87.
33. Letterio J.J., Roberts A.B. TGF-beta. a critical modulator of immune cell function Clin. Immunol. Immunopathol. 84:1997;244-250.
34. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:1998;137-161.
35. Letterio J.J., Geiser A.G., Kulkarni A.B., Dang H., Kong L., Nakabayashi T., Mackall C.L., Gress R.E., Roberts A.B. Autoimmunity associated with TGF-β1 deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:1996;2109-2119.
36. Longenecker G., Thyagarajan T., Nagineni C.N., Flanders K.C., Factor V., Miller G., Ward J.M., Nalca A., Rangnekar V.M., Thorgeirsson S., Kulkarni A.B. Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype. Cytokine. 18:2002;43-50.
37. Loskutoff D.J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9:1989;87-115.
38. Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res. Brain Res. Rev. 23:1997;1-27.
39. Masliah E., Achim C.L., Ge N., DeTeresa R., Terry R.D., Wiley C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32:1992;321-329. a.
40. Masliah E., Ge N., Morey M., DeTeresa R., Terry R.D., Wiley C.A. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66:1992;285-291. b.
41. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
42. Massagué J., Blain S.W., Lo R.S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
43. McCartney-Francis N.L., Wahl S.M. Transforming growth factor β A matter of life and death J. Leukoc. Biol. 55:1994;401-409.
44. Mehler M.F., Mabie P.C., Zhang D., Kessler J.A. Bone morphogenetic proteins in the nervous system. Trends Neurosci. 20:1997;309-317.
45. Minichiello L., Klein R. TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev. 10:1996;2849-2858.
46. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68:1992;869-877.
47. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., Rifkin D.B. Latent transforming growth factor-β Structural features and mechanisms of activation Kidney Int. 51:1997;1376-1382.
48. Roberts A.B., Sporn M.B. Transforming growth factor-β Clark R.A.F. The Molecular and Cellular Biology of Wound Repair. 1996;275-308 Plenum Press, New York.
49. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci. 18:1995;57-58.
50. Schauwecker P.E., Steward O. Genetic determinants of susceptibility to excitotoxic cell death. Implications for gene targeting approaches Proc. Natl. Acad. Sci. USA. 94:1997;4103-4108.
51. Schober A., Hertel R., Arumäe U., Farkas L., Jaszai J., Krieglstein K. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-β as cofactor in vivo. J. Neurosci. 19:1999;2008-2015.
52. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D.et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
53. Sometani A., Kataoka H., Nitta A., Fukumitsu H., Nomoto H., Furukawa S. Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. J. Neurosci. Res. 66:2001;369-376.
54. Sweeney S.T., Davis G.W. Unrestricted synaptic growth in spinster - a late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation. Neuron. 36:2002;403-416.
55. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease. Synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30:1991;572-580.
56. Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., Van Leuven F. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol. 157:2000;1495-1510.
57. Tsirka S.E., Rogrove A.D., Strickland S. Neuronal cell death and tPA. Nature. 384:1996;123-124.
58. Unsicker K., Krieglstein K. Co-activation of TGF-β and cytokine signaling pathways are required for neurotrophic functions. Cytokine Growth Factor Rev. 11:2000;97-102.
59. Unsicker K., Krieglstein K. TGF-betas and their roles in the regulation of neuron survival. Adv. Exp. Med. Biol. 513:2002;353-374.
60. Venstrom K.A., Reichardt L.F. Extracellular matrix. 2. Role of extracellular matrix molecules and their receptors in the nervous system FASEB J. 7:1993;996-1003.
61. Weinstein M., Yang X., Deng C.-X. Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev. 11:2000;49-58.
62. Wyss-Coray T., Feng L., Masliah E., Ruppe M.D., Lee H.S., Toggas S.M., Rockenstein E.M., Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am. J. Pathol. 147:1995;53-67.
63. Wyss-Coray T., Lin C., Sanan D., Mucke L., Masliah E. Chronic overproduction of TGF-β1 in astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156:2000;139-150.
64. Wyss-Coray T., Lin C., Yan F., Yu G., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:2001;614-618.
65. Xu B., Zang K., Ruff N.L., Zhang Y.A., McConnell S.K., Stryker M.P., Reichardt L.F. Cortical degeneration in the absence of neurotrophin signaling. Dendritic retraction and neuronal loss after removal of the receptor TrkB Neuron. 26:2000;233-245.
66. Zhang F., Endo S., Cleary L.J., Eskin A., Byrne J.H. Role of transforming growth factor-β in long-term synaptic facilitation in Aplysia. Science. 275:1997;1318.
67. Zheng X., Wang J., Haerry T.E., Wu A.Y., Martin J., O'Connor M.B., Lee C.H., Lee T. TGF-beta signaling activates steroid hormone receptor expression during neuronal remodeling in the Drosophila brain. Cell. 112:2003;303-315.